India to United States: Amino Export Trade Route
India has recorded 2,687 verified shipments of Amino exported to United States, representing a combined trade value of $135.4M USD. This corridor is served by 52 active Indian exporters, with an average shipment value of $50.4K USD. The leading Indian exporter is GRANULES INDIA LIMITED, which accounts for 64% of total export value with 1,331 shipments worth $86.2M USD. On the buying side, GRANULES CONSUMER HEALTH is the largest importer in United States with $49.0M USD in purchases. The top 3 suppliers — GRANULES INDIA LIMITED, ELYSIUM PHARMACEUTICALS LTD, MARKSANS PHARMA LIMITED — together control 80% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Amino corridor is one of India's established pharmaceutical export routes, with 2,687 shipments documented worth a combined $135.4M USD. The route is dominated by GRANULES INDIA LIMITED, which alone accounts for roughly 64% of all export value, reflecting the consolidated nature of India's amino manufacturing sector.
Across 52 active suppliers, the average shipment value stands at $50.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with amino's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 30.2%, placing it at rank #8 among India's top amino export destinations globally.
On the import side, key buyers of Indian amino in United States include GRANULES CONSUMER HEALTH, GRANULES USA INC, SPIRIT PHARMACEUTICALS LLC and 112 others. GRANULES CONSUMER HEALTH is the single largest importer with 751 shipments valued at $49.0M USD.
